The Hippo-YAP pathway regulates organ size by modulating cell proliferation and apoptosis. Yu et al. now reveal that G-protein-coupled receptors act upstream of the transcriptional coactivators YAP/TAZ. This study reinforces the connection between the actin cytoskeleton and Hippo pathway activity and identifies a class of secreted extracellular regulators of YAP/TAZ activity.
The Hippo pathway has major roles in the modulation of cell proliferation, apoptosis, migration, and differentiation. It is essential both during developmental growth and in maintaining homeostasis of adult organs, and when deregulated it can cause tumorigenesis (Pan, 2010) . The first description of the pathway came from the discovery of connections between the Drosophila tumor suppressors Hippo, Salvador, and Warts. Subsequent studies have identified an ever-increasing number of pathway components and firmly established its importance as a conserved regulator of organ growth. The core of the Hippo pathway comprises two Ser/Thr kinases, Hippo (Mst1/2 in mammals) and Warts (Lats1/2 in mammals), which act sequentially, with Mst1/2 responsible for activating Lats1/2. Under nonproliferating conditions, this module represses growth by phosphorylating the homologous transcriptional coactivators YAP and TAZ, leading to their retention in the cytoplasm and to their degradation. When YAP/TAZ are not phosphorylated by LATS kinases, they accumulate in the nucleus, where they associate with DNA-binding proteins such as TEAD, leading to the expression of genes that promote cell proliferation (Pan, 2010; Staley and Irvine, 2012) .
Central to understanding the role of this pathway is elucidation of the mechanisms that regulate the activity of the MST-LATS-YAP core. Several different upstream regulators have been described, involving diverse molecules, but common features have emerged: Hippo signaling is regulated by cell contact and cell polarity, and proteins identified as upstream regulators have generally been proteins associated with cell junctions.
The work from Yu et al. (2012) presented in this issue identifies a new class of Hippo pathway regulators. Their discovery stems from an elegant biochemical characterization of the influence of serum on Yap activity in cultured cells, which reveals that phospholipids present in serum, lysophosphatidic acid (LPA), and sphingosine 1-phosphophate (S1P) could elevate YAP/TAZ activity. They show that these phospholipids act through G-protein-coupled receptors (GPCRs). GPCRs comprise a large family of cellsurface molecules involved in signal transduction, and while the action of LPA and S1P is specifically related to GPCRs that act through the G proteins G12 and G13, Yu et al. show that a wide range of G proteins can potentially influence LATS activity, with G i class G proteins activating LATS and thereby repressing YAP/TAZ, whereas G s class G proteins inhibit LATS and thereby activate YAP/TAZ.
GPCRs comprise the largest family of cell-surface molecules involved in signal transmission (Dorsam and Gutkind, 2007) . Given the enormous number of GPCRs and their agonists, the Yu et al. study raises the possibility that a wide range of secreted signals could modulate growth through the Hippo pathway. Moreover, they provide evidence that some functions previously ascribed to G protein signaling, such as effects of LPA on cell migration and cell proliferation, could be mediated through YAP/TAZ. Thus, depending on the cell environment, hormones, developmental stage, and, of course, the localization and expression of GPCRs, a multitude of possible effects on cells involving GPCR-Hippo pathway connections needs to be considered. More studies are needed to evaluate the significance of the GPCR-Hippo connection to normal development and physiology, but Yu et al. provide some hints by documenting effects of other GPCR ligands, such as epinephrine and glucagon, on YAP/TAZ phosphorylation. It will also be important to investigate whether YAP/TAZ activation contributes to the many cancers in which GPCRs are overexpressed or activated.
Although the discovery of G protein regulation of Hippo signaling is unanticipated, recent discoveries of how the F-actin cytoskeleton and mechanical tension influence YAP/TAZ activity provides a basis for beginning to understanding how G protein activity is linked to regulation of YAP/TAZ (Figure 1 ). Studies first in Drosophila and subsequently in cultured mammalian cells reveal that disruption of genes that limit F-actin polymerization lead to activation of YAP/TAZ or its Drosophila homolog, Yorkie, evidently through inhibition of LATS/Warts (Ferná ndez et al., 2011; Sansores-Garcia et al., 2011) . F-actin is also implicated in LATS regulation by cell attachment or altered cell morphology . Meanwhile, variations in cytoskeletal tension, such as what cells experience when cultured on substrates of different elasticities, modulate YAP/TAZ activity through an unknown mechanism that appears independent of Hippo signaling but depends upon the GTPase Rho, which is a regulator of actin polymerization and ROCK/Myosin activity (Dupont et al., 2011) . Moreover, although MST1/2 is predominantly cytoplasmic, a small proportion is associated with the actin cytoskeleton and can be activated by actin disruption (Densham et al., 2009 ). Yu et al. find that G12/13 regulation of YAP/TAZ is dependent upon both Rho and F-actin and independent of MST and ROCK. Thus, although some aspects of these studies appear in conflict (such as whether Rhodependent modulation of YAP/TAZ is dependent upon LATS), overall, they suggest that YAP/TAZ activity can be modulated by a wide range of processes that impinge upon F-actin organization, including GPCRs. They also imply that the balance between modulators of actin structures will be crucial for the final cellular response through YAP/TAZ. The influence of serum on YAP/TAZ is mostly transient, and the dynamic nature of these pathways will also be an important consideration for future investigations of how GPCR effects are integrated with other cytoskeletal modulators.
Nevertheless, the next step remains elusive: what are the mechanisms by which Rho or F-actin promote nuclear localization of YAP/TAZ? Evidence suggests that, depending upon the stimulus, they may initiate a Lats-dependent or Lats-independent cascade, but how are they connected? The beginning of a possible hypothesis arises from the observation that some regulators of YAP/TAZ or LATS also have the ability to bind actin or to modulate actin organization, including Zyxin, Expanded, NF2/Merlin, and Ajuba. Changes in F-actin might affect the localization or activity of these proteins in some way, but mechanistic studies are needed to solve this mystery. With the rapid pace of progress in the Hippo field, it may not be long before the next series of studies will lead us to understand the journey that begins with the activation of receptors through the actin filaments to the core of the Hippo pathway and the regulation of YAP/TAZ. A schematic of the Hippo signaling pathway is depicted (for simplification, many components have been omitted). Modulation of F-actin dynamics is essential for the regulation of YAP/TAZ by several upstream pathways. Binding of extracellular ligands of GPCRs, or cell attachment, stimulates the Hippo signaling pathway positively or negatively through Lats1/2 by an unknown mechanism that requires Rho and F-actin. Conversely, mechanical cues seem to act independently of Lats1/2 to trigger the activation of YAP/TAZ. Cell-cell contact, which can be mediated by a number of junctional complexes, including Merlin-containing complexes, can inhibit YAP through MST/LATS. Other junctional complexes (not shown) can act independently of MST.
